A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy

Table 7

Variables used in the regression analyses to determine if the variable is useful in explaining a particular outcome measure and the coefficients and significance level of those which reached the 0.05 significance level.

Independent variable	Final pain score	Change in pain	% improvement	Change in sleep	Change in physical activity	Change in QoL	Change in meds
Demographics
Gender (women)
Age						−0.013 (0.1)
Etiology/location
Arthritis
Fibromyalgia				−0.364 (0.03)
Back
Knee
Other location
Pain intensity
Baseline		1.10 (00)	0.058 (00)			0.112 (0.04)	0.153 (0.02)
Duration	0.045 (00)	−0.044 (00)	−0.005 (02)				−0.038 (0.00)
Current treatment
OTC meds							0.356 (00)
Use of opiate meds
Other therapies							−0.186 (0.01)
7-day pain level	0.613 (00)	−0.633 (00)	−0.074 (00)	−0.079 (0.04)	−0.080 (0.04)	−1.87 (00)	−0.264 (00)
R^2	0.36	0.48	0.32	0.10	0.08	0.18	0.27